ClinConnect ClinConnect Logo
Search / Trial NCT06427096

Effect of Healthy Family Program on Population Blood Pressure

Launched by HEART HEALTH RESEARCH CENTER · May 18, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

The clinical trial titled "Effect of Healthy Family Program on Population Blood Pressure" is studying ways to help lower blood pressure in families living in Ruyang County, China. The trial involves 80 villages, where some will be part of a special program while others will continue with their usual healthcare. Families in the program will work with local instructors to adopt healthier habits, like eating less salt, exercising regularly, and keeping track of their blood pressure. The main goal is to see if these changes help reduce blood pressure levels after six months compared to those who are not participating in the program.

To be eligible for this study, families need to have at least two members aged 40 to 80 years who are willing to participate. It’s important that at least one family member can use a smartphone to share their blood pressure readings. Participants should not have serious health issues like advanced cancer or kidney disease, and they shouldn’t be involved in other blood pressure programs. If you or a family member fits these criteria, you could play a significant role in this important research aimed at improving heart health in your community!

Gender

ALL

Eligibility criteria

  • 1. Village screening:
  • The suitable villages were initially screened according to the statistical information of the number of villages and households in Ruyang County.
  • 2. Inclusion and Exclusion Criteria for the Family
  • Inclusion Criteria:
  • 1. At least 2 participants between the age of 40-80 years meet the inclusion and exclusion criteria of family members and willing to participate in this study;
  • 2. At least one family member can use the smartphone to upload BP values.
  • Exclusion Criteria:
  • 1. Any family member participated in the other hypertension-related programs;
  • 2. Inappropriate for the study decided by the healthy family instructor.
  • 3.Inclusion and Exclusion Criteria for the Family Member
  • Inclusion Criteria:
  • 1. 40-80 years old, regardless of BP level and antihypertensive treatment;
  • 2. No travel plan for more than 1 month during the study period;
  • 3. Written or fingerprinted informed consent form.
  • Exclusion Criteria:
  • 1. Significant cognitive dysfunction;
  • 2. With advanced tumor, dialysis, or other serious diseases;
  • 3. Lying in bed for a long time or unable to take care of themselves;
  • 4. Diagnosed of secondary hypertension;
  • 5. Having birth plans in the next six months, pregnant or lactating women;
  • 6. Other ineligible circumstances judged by the investigators.

About Heart Health Research Center

Heart Health Research Center is a leading clinical trial sponsor dedicated to advancing cardiovascular medicine through rigorous research and innovative studies. With a commitment to improving heart health, the center conducts clinical trials that explore new therapies, interventions, and prevention strategies for a range of cardiovascular conditions. Our multidisciplinary team of experts collaborates with healthcare professionals and academic institutions to ensure the highest standards of scientific integrity and patient safety. By fostering partnerships and leveraging cutting-edge technology, Heart Health Research Center aims to contribute significantly to the understanding and treatment of heart disease, ultimately enhancing patient outcomes and quality of life.

Locations

Luoyang, Henan, China

Patients applied

0 patients applied

Trial Officials

Jun Cai, MD

Principal Investigator

Beijing Anzhen Hospital

Xin Du, MD

Principal Investigator

Beijing Anzhen Hospital

Craig S Anderson, MD

Principal Investigator

Institute of Science and Technology for Brain-Inspired Intelligence

Chao Jiang, MD

Principal Investigator

Beijing Anzhen Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported